More than 30,000 cancer specialists attended the recent American Society of Clinical Oncology conference in Chicago, the American Cancer Society said.
At the conference, titled "Making a Difference in Cancer Care With You," cancer specialists from around the world met to discuss medical findings, clinical trials and new prescription drug cases to help cancer patients.
Findings presented included one for PolyBalm, intended to treat nail damage of cancer patients undergoing radiation.
“There was clearly a need to try and solve this issue for patients," Dr. Robert Thomas said in a release.
The patients who saw positive success from the balm applied it three times per day and at the end of the 30 day trial all but two patients had nails that were were stronger and less damaged.
In another study presented at the conference, a 1b JAVELIN Renal 100 Trial, showed promise that a drug combination aided patients who suffer from advanced renal cell carcinoma.
